Ibaraki, Japan

Tokuyuki Shinohara

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tokuyuki Shinohara. Retrieved from https://idiyas.com/inventor/tokuyuki-shinohara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tokuyuki Shinohara: Innovator in IL-13 Production Inhibition

Introduction: Tokuyuki Shinohara is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical research, particularly in the development of inhibitors for IL-13 production. His work is crucial for advancing therapeutic options for respiratory diseases.

Latest Patents: Tokuyuki Shinohara holds 1 patent related to an IL-13 production inhibitor. This invention provides a screening method and kit for identifying IL-13 production inhibitors. The method involves using a protein with a specific amino acid sequence and a ligand that binds to this protein. The inhibitors obtained through this screening process are valuable as prophylactic and therapeutic agents for respiratory diseases.

Career Highlights: Tokuyuki Shinohara is associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda emphasizes the importance of innovative research in developing new treatments for various health conditions.

Collaborations: Throughout his career, Tokuyuki has collaborated with esteemed colleagues, including Kazuhiro Ogi and Yusuke Kikukawa. These collaborations have further enhanced the research and development efforts in the field of IL-13 inhibitors.

Conclusion: Tokuyuki Shinohara's contributions to the field of medical research, particularly through his patent on IL-13 production inhibitors, highlight his role as an innovator. His work continues to pave the way for advancements in therapeutic solutions for respiratory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…